4/9/2024 | BK | Fitch pares Bayou Intermediate II
|
4/12/2023 | BK | Fitch cuts Cordis
|
10/28/2022 | BK | Fitch puts Cordis on watch
|
5/13/2021 | BK | Market Commentary: Doosan, Columbus McKinnon, Cordis break; Pathway, Sound Physicians, Kenan, Conair updated
|
5/13/2021 | CLHY | Market Commentary: Doosan, Columbus McKinnon, Cordis break; Pathway, Sound Physicians, Kenan, Conair updated
|
5/12/2021 | BK | Market Commentary: Therapy Brands breaks; Club Car, Cordis, SRAM revised; Sound Physicians tweaks timing
|
5/12/2021 | CLHY | Market Commentary: Therapy Brands breaks; Club Car, Cordis, SRAM revised; Sound Physicians tweaks timing
|
5/12/2021 | BK | Cordis lifts term loan B to $375 million, firms at Libor plus 450 bps
|
4/29/2021 | BK | Market Commentary: United Pacific, Ahead DB, Insulet, Mitratech break; PQ, Cubic, Alliant updates surface
|
4/29/2021 | CLHY | Market Commentary: United Pacific, Ahead DB, Insulet, Mitratech break; PQ, Cubic, Alliant updates surface
|
4/29/2021 | BK | Cordis launches $350 million term loan B at Libor plus 450-475 bps
|
4/28/2021 | BK | Moody's assigns Bayou Intermediate B2
|
4/28/2021 | BK | S&P rates Cordis parent, loans B-
|
4/27/2021 | BK | Market Commentary: Birkenstock breaks; Insulet, Press Ganey, Surgery Partners tweak deals; PQ moves deadline
|
4/27/2021 | CLHY | Market Commentary: Birkenstock breaks; Insulet, Press Ganey, Surgery Partners tweak deals; PQ moves deadline
|
4/27/2021 | BK | Cordis readies launch of $350 million term loan B for Thursday
|
4/27/2021 | BK | Fitch gives Cordis BB-
|
3/12/2021 | BK | Cordis plans new financing for buyout by Hellman & Friedman
|
9/26/2006 | BT | Cordis: FDA approves stent system for carotid artery disease
|
9/13/2006 | BT | Cordis: study shows Cypher stent reduces vessel failure by 50%
|
9/6/2006 | BT | Cordis gets European approval for stent to treat arterial disease in the leg
|
9/6/2006 | BT | Cordis: Cypher stent provides sustained benefits in coronary artery disease patients
|
9/5/2006 | BT | Cordis' Cypher stent slightly more effective than Taxus stent, data shows
|
8/29/2006 | BT | Cordis to release study data, promote new products at World Congress of Cardiology
|
7/27/2006 | BT | Cordis' Cypher stent more cost-effective than Taxus stent, study says
|
7/17/2006 | BT | Cordis: Overlapping Cypher stents more effective than overlapping bare metal stents
|
6/22/2006 | BT | Cordis' CypherSelect Plus stent approved in Europe
|
5/17/2006 | BT | Cordis submits PMA supplement for direct stenting
|
5/16/2006 | BT | Cordis study suggests drug-eluting stent, size important reblockage predictors
|
5/15/2006 | BT | Cordis patient registry to evaluate long-term safety, efficacy of drug-eluting coronary stents
|
4/3/2006 | BT | Cordis reports one-year follow-up data for Cypher stent matches clinical trials
|
3/27/2006 | BT | Cordis says district judge upholds patent infringement verdicts against Boston Scientific, Medtronic
|
3/8/2006 | BT | Cordis to present clinical data for Cypher Stent in heart attacks at ACC 2006
|
12/21/2005 | BT | Cordis says new data shows Cypher stent better than Taxus for patients with hard-to-treat lesions
|